Aspen is a significant global pharma company with a focus on anesthetics, anti-coagulants and infant milk formula. It has a market cap of R139.6 billion, a PE of 23.55 and a dividend yield of 0.94 per cent. Guest Nesan Nair, Sasfin Securities and resident expert Paul Theron from Vestact decide whether Aspen is hot or not.